Matrix Capital Management Company, LP - Dec 5, 2022 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
10%+ Owner
Signature
Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner
Stock symbol
AURA
Transactions as of
Dec 5, 2022
Transactions value $
$15,000,000
Form type
4
Date filed
12/7/2022, 03:30 PM
Previous filing
Jun 3, 2022
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock, par value $0.00001 per share ("Common Stock") Purchase $15M +1.25M +30.39% $12.00 5.36M Dec 5, 2022 See footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.
F2 The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.